ImmuCell Corp announced on December 24, 2025, that it will incur a non-cash impairment write-down of approximately $2.3 million related to production assets while shifting focus to its First Defense® franchise. This update follows the receipt of an Incomplete Letter from the FDA for its Re-Tain® product application on December 23, 2025.